- Home
- AGMB vs PACK Comparison
AGMB vs PACK Comparison
Compare AGMB & PACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMB | PACK |
|---|---|---|
| Founded | 2017 | 1972 |
| Country | Belgium | United States |
| Employees | 62 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Containers/Packaging |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.4M | 653.6M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | AGMB | PACK |
|---|---|---|
| Price | $11.69 | $6.98 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $32.00 | $6.50 |
| AVG Volume (30 Days) | 103.4K | ★ 545.5K |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $395,000,000.00 |
| Revenue This Year | N/A | $9.29 |
| Revenue Next Year | $17.86 | $8.35 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.08 |
| 52 Week Low | $8.75 | $3.22 |
| 52 Week High | $17.82 | $7.81 |
Technical Indicators
Market Signals| Indicator | AGMB | PACK |
|---|---|---|
| Relative Strength Index (RSI) | 46.10 | 53.29 |
| Support Level | $11.53 | $6.59 |
| Resistance Level | $12.53 | $7.15 |
| Average True Range (ATR) | 1.01 | 0.30 |
| MACD | -0.22 | -0.02 |
| Stochastic Oscillator | 14.44 | 82.27 |
Price Performance
Historical ComparisonAbout AGMB AgomAb Therapeutics NV American Depositary Shares
AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.
About PACK Ranpak Holdings Corp
Ranpak Holdings Corp is a provider of environmentally sustainable, systems-based, product protection solutions for e-Commerce and industrial supply chains. The company offers a full suite of protective packaging systems and paper consumables. The group generates revenue by providing its PPS systems and paper consumables to customers, which include direct end-users and a network of exclusive paper packaging solution distributors, and by providing end-of-line automation systems that solve challenges, including optimization, customization, and efficiency. It has two segments, North America and Europe/Asia.